Research & Literature

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Kunkler IH, Williams LJ, Jack WJ, et al.

The Lancet. Oncology 2015; (16(3)):266-73.

Molecular phenotypes of DCIS predict overall and invasive recurrence.

Williams KE, Barnes NLP, Cramer A, et al.

Annals of oncology : official journal of the European Society for Medical Oncology 2015; (26(5)):1019-1025 doi:10.1093/annonc/mdv062.

Regional Nodal Irradiation in Early-Stage Breast Cancer.

Whelan TJ, Olivotto IA, Parulekar WR, et al.

The New England journal of medicine 2015; (373(4)):307-16 doi:10.1056/NEJMoa1415340.

Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer.

DeSnyder SM, Hunt KK, Smith BD, et al.

Annals of surgical oncology 2015; (22(10)):3250-6 doi:10.1245/s10434-015-4666-1.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Lancet (London, England) 2015; (386(10001)):1341-1352 doi:10.1016/S0140-6736(15)61074-1.

Frequency and Clinical Significance of Extramammary Findings on Breast Magnetic Resonance Imaging.

Phadke S, Thomas A, Yang L, et al.

Clinical breast cancer 2016; (16(5)):424-429 doi:10.1016/j.clbc.2015.08.003.

The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index.

Arima N, Nishimura R, Osako T, et al.

Journal of clinical pathology 2016; (69(3)):255-9 doi:10.1136/jclinpath-2015-203174.

Breast Cancer Subtype is Associated With Axillary Lymph Node Metastasis: A Retrospective Cohort Study.

He ZY, Wu SG, Yang Q, et al.

Medicine 2015; (94(48)):e2213 doi:10.1097/MD.0000000000002213.

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

Runowicz CD, Leach CR, Henry NL, et al.

CA: a cancer journal for clinicians 2016; (66(1)):43-73 doi:10.3322/caac.21319.

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

Runowicz CD, Leach CR, Henry NL, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(6)):611-35 doi:10.1200/JCO.2015.64.3809.

Do All Women With Abnormal Sonographic Axillary Lymph Nodes Need a Biopsy?

Amitai Y, Menes T, Aviram G, Golan O

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016; (67(2)):173-8.

Adult cystic lymphangioma in the inner quadrant of the breast-Rare location for a rare disease: A case report.

Rusdianto E, Murray M, Davis J, Caveny A

International journal of surgery case reports 2016; (20()):123-6.

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression.

Burstein HJ, Lacchetti C, Anderson H, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(14)):1689-701 doi:10.1200/JCO.2015.65.9573.

Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.

Lavoué V, Fritel X, Antoine M, et al.

European journal of obstetrics, gynecology, and reproductive biology 2016; (200()):16-23.

Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer: A Review.

Speers C, Pierce LJ

JAMA oncology 2016; (2(8)):1075-82 doi:10.1001/jamaoncol.2015.5805.

Micro- and macro-metastasis in the axillary lymph node: A review.

Naidoo K, Pinder SE

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 2017; (15(2)):76-82 doi:10.1016/j.surge.2016.07.002.

Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options.

Shah C, Tendulkar R, Smile T, et al.

Annals of surgical oncology 2016; (23(12)):3880-3890 doi:10.1245/s10434-016-5503-x.

Close and Positive Lumpectomy Margins are Associated with Similar Rates of Residual Disease with Additional Surgery.

Fitzgerald S, Romanoff A, Cohen A, et al.

Annals of surgical oncology 2016; (23(13)):4270-4276 doi:10.1245/s10434-016-5490-y.

Identification and management of women with a family history of breast cancer: Practical guide for clinicians.

Heisey R, Carroll JC

Canadian family physician Medecin de famille canadien 2016; (62(10)):799-803.

ACR Appropriateness Criteria Palpable Breast Masses.

Harvey JA, Mahoney MC, Newell MS, et al.

Journal of the American College of Radiology : JACR 2016; (13(11S)):e31-e42 doi:10.1016/j.jacr.2016.09.022.

ACR Appropriateness Criteria® Palpable Breast Masses.

, Moy L, Heller SL, et al.

Journal of the American College of Radiology : JACR 2017; (14(5S)):S203-S224 doi:10.1016/j.jacr.2017.02.033.

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

von Minckwitz G, Procter M, de Azambuja E, et al.

The New England journal of medicine 2017; (377(2)):122-131 doi:10.1056/NEJMoa1703643.

Oncoplastic breast surgery in the setting of breast-conserving therapy: A systematic review.

Yoon JJ, Green WR, Kim S, et al.

Advances in radiation oncology 2016; (1(4)):205-215 doi:10.1016/j.adro.2016.09.002.

Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer.

Bracken-Clarke DB, Lucas MW, Higgins MJ

Breast care (Basel, Switzerland) 2017; (12(3)):138-144 doi:10.1159/000477956.

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Giuliano AE, Ballman KV, McCall L, et al.

JAMA 2017; (318(10)):918-926 doi:10.1001/jama.2017.11470.

A computable pathology report for precision medicine: extending an observables ontology unifying SNOMED CT and LOINC.

Campbell WS, Karlsson D, Vreeman DJ, et al.

Journal of the American Medical Informatics Association : JAMIA 2018; (25(3)):259-266 doi:10.1093/jamia/ocx097.

Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis.

Zhao M, Liu WG, Zhang L, et al.

Chronic diseases and translational medicine 2017; (3(1)):41-50 doi:10.1016/j.cdtm.2017.01.005.

Evaluating imaging-pathology concordance and discordance after ultrasound-guided breast biopsy.

Park VY, Kim EK, Moon HJ, et al.

Ultrasonography (Seoul, Korea) 2018; (37(2)):107-120 doi:10.14366/usg.17049.

Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.

Frampton JE

Drugs 2017; (77(18)):2037-2048 doi:10.1007/s40265-017-0849-3.

Early re-staging and molecular subtype shift surveillance of locally recurrent or metastatic breast cancer: A new PET/CT integrated precise algorithm.

Guo W, Hao B, Luo N, et al.

Cancer letters 2018; (418()):221-229 doi:10.1016/j.canlet.2018.01.019.

Margins in breast cancer: How much is enough?

Pilewskie M, Morrow M

Cancer 2018; (124(7)):1335-1341 doi:10.1002/cncr.31221.

Bone health during endocrine therapy for cancer.

Rachner TD, Coleman R, Hadji P, Hofbauer LC

The lancet. Diabetes & endocrinology 2018; (6(11)):901-910 doi:10.1016/S2213-8587(18)30047-0.

Non-randomness of the anatomical distribution of tumors.

Yu C, Mitchell JK

Cancer convergence 2017; (1(1)):4 doi:10.1186/s41236-017-0006-7.

Comparing exercise responses to aerobic plus resistance training between postmenopausal breast cancer survivors undergoing aromatase inhibitor therapy and healthy women.

de Paulo TRS, Winters-Stone KM, Viezel J, et al.

Disability and rehabilitation 2019; (41(18)):2175-2182 doi:10.1080/09638288.2018.1460877.

Value of ultrasound-guided fine needle aspiration in diagnosing axillary lymph node recurrence after breast cancer surgery.

Park VY, Kim EK, Moon HJ, et al.

American journal of surgery 2018; (216(5)):969-973 doi:10.1016/j.amjsurg.2018.04.012.

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Sparano JA, Gray RJ, Makower DF, et al.

The New England journal of medicine 2018; (379(2)):111-121 doi:10.1056/NEJMoa1804710.

Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.

Grossmith S, Nguyen A, Hu J, et al.

Annals of surgical oncology 2018; (25(12)):3527-3534 doi:10.1245/s10434-018-6525-3.

Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer

Sandoughdaran S, Malekzadeh M, Mohammad Esmaeil ME

Asian Pacific journal of cancer prevention : APJCP 2018; (19(6)):1617-1620 doi:10.22034/APJCP.2018.19.6.1617.

Tumor Site and Breast Cancer Prognosis.

Siotos C, McColl M, Psoter K, et al.

Clinical breast cancer 2018; (18(5)):e1045-e1052 doi:10.1016/j.clbc.2018.05.007.

Women's Rehabilitation Experiences Following Breast Cancer Surgery.

Reigle BS, Zhang B

Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses 2018; (43(4)):195-200 doi:10.1097/rnj.0000000000000168.

Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System: Review of the Supporting Evidence.

Weiss A, King TA, Hunt KK, Mittendorf EA

The Surgical clinics of North America 2018; (98(4)):687-702 doi:10.1016/j.suc.2018.03.005.

Laryngeal metastases from breast cancer: A rare clinical entity.

Kumar R, Kumar S, Gogia A, et al.

Current problems in cancer 2019; (43(2)):130-134 doi:10.1016/j.currproblcancer.2018.07.010.

Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Gillespie TC, Sayegh HE, Brunelle CL, et al.

Gland surgery 2018; (7(4)):379-403 doi:10.21037/gs.2017.11.04.

New and Important Changes in the TNM Staging System for Breast Cancer.

Hortobagyi GN, Edge SB, Giuliano A

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018; (38()):457-467 doi:10.1200/EDBK_201313.

Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials.

Yan M, Abdi MA, Falkson C

Clinical breast cancer 2018; (18(6)):e1251-e1259 doi:10.1016/j.clbc.2018.08.002.

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

von Minckwitz G, Huang CS, Mano MS, et al.

The New England journal of medicine 2019; (380(7)):617-628 doi:10.1056/NEJMoa1814017.

Why do newly diagnosed breast cancer patients seek a second opinion? - Second opinion seeking and its association with the physician-patient relationship.

Cecon N, Hillen MA, Pfaff H, et al.

Patient education and counseling 2019; (102(5)):998-1004 doi:10.1016/j.pec.2018.12.017.

Breast Cancer Treatment: A Review.

Waks AG, Winer EP

JAMA 2019; (321(3)):288-300 doi:10.1001/jama.2018.19323.

Primary Care of Breast Cancer Survivors.

Zoberi K, Tucker J

American family physician 2019; (99(6)):370-375.

Breast cancer.

Harbeck N, Penault-Llorca F, Cortes J, et al.

Nature reviews. Disease primers 2019; (5(1)):66 doi:10.1038/s41572-019-0111-2.

[Diagnostic value of digital breast tomosynthesis for mass lesions in dense breast].

Lü XJ, Liu N, Li Q, et al.

Zhonghua yi xue za zhi 2019; (99(39)):3110-3113 doi:10.3760/cma.j.issn.0376-2491.2019.39.014.

[Strategies in case of metastatic sentinel lymph node in breast cancer].

Costaz H, Rouffiac M, Boulle D, et al.

Bulletin du cancer 2020; (107(6)):672-685 doi:10.1016/j.bulcan.2019.09.005.

Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer.

Jeong YS, Kang J, Lee J, et al.

Journal of pathology and translational medicine 2020; (54(1)):87-94 doi:10.4132/jptm.2019.10.14.

Percutaneous Ultrasound-Guided Core Needle Biopsy: Comparison of 16-Gauge versus 14-Gauge Needle and the Effect of Coaxial Guidance in 1065 Breast Biopsies - A Prospective Randomized Clinical Noninferiority Trial.

Gruber I, Oberlechner E, Heck K, et al.

Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2020; (41(5)):534-543 doi:10.1055/a-1014-2628.

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.

Allison KH, Hammond MEH, Dowsett M, et al.

Archives of pathology & laboratory medicine 2020; (144(5)):545-563 doi:10.5858/arpa.2019-0904-SA.

Pembrolizumab for Early Triple-Negative Breast Cancer.

Schmid P, Cortes J, Pusztai L, et al.

The New England journal of medicine 2020; (382(9)):810-821 doi:10.1056/NEJMoa1910549.

Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center.

Loehberg CR, Meyer J, Häberle L, et al.

Archives of gynecology and obstetrics 2020; (301(5)):1299-1306 doi:10.1007/s00404-020-05525-2.

The Landmark Series: Adjuvant Radiation Therapy for Breast Cancer.

Valente SA, Shah C

Annals of surgical oncology 2020; (27(7)):2203-2211 doi:10.1245/s10434-020-08450-5.

The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution.

Tokunaga E, Ijichi H, Tajiri W, et al.

Breast cancer (Tokyo, Japan) 2020; (27(6)):1137-1146 doi:10.1007/s12282-020-01116-w.

Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.

Liu S, Wang N, Gao P, et al.

World journal of surgical oncology 2020; (18(1)):118 doi:10.1186/s12957-020-01886-9.

Neoadjuvant treatment for HER2-positive breast cancer.

Takada M, Toi M

Chinese clinical oncology 2020; (9(3)):32 doi:10.21037/cco-20-123.

The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis.

Shah C, Hobbs BP, Vicini F, et al.

Annals of surgical oncology 2020; (27(12)):4628-4636 doi:10.1245/s10434-020-08878-9.

Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.

Naoum GE, Roberts S, Brunelle CL, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(29)):3430-3438 doi:10.1200/JCO.20.00459.

Association between body mass index and localization of breast cancer: results from a nationwide inpatient database in Japan.

Konishi T, Fujiogi M, Michihata N, et al.

Breast cancer research and treatment 2021; (185(1)):175-182 doi:10.1007/s10549-020-05934-6.

Extended Endocrine Therapy for Early-Stage Breast Cancer: How Do We Decide?

Walsh EM, Nunes R, Wilkinson MJ, Santa-Maria CA

Current oncology reports 2020; (22(12)):123 doi:10.1007/s11912-020-00988-7.

Long-term safety and efficacy of breast biopsy markers in clinical practice.

Smith S, Taylor CR, Kanevsky E, et al.

Expert review of medical devices 2021; (18(1)):121-128 doi:10.1080/17434440.2020.1852928.

The nature of triple-negative breast cancer classification and antitumoral strategies.

Kim S, Kim DH, Lee W, et al.

Genomics & informatics 2020; (18(4)):e35 doi:10.5808/GI.2020.18.4.e35.

Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement.

Freedman RA, Minami CA, Winer EP, et al.

JAMA oncology 2021; (7(4)):609-615 doi:10.1001/jamaoncol.2020.7582.

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.

Korde LA, Somerfield MR, Carey LA, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021; (39(13)):1485-1505 doi:10.1200/JCO.20.03399.

Lobular Breast Cancer: A Review.

Wilson N, Ironside A, Diana A, Oikonomidou O

Frontiers in oncology 2020; (10()):591399 doi:10.3389/fonc.2020.591399.

Managing Common Estrogen Deprivation Side Effects in HR+ Breast Cancer: an Evidence-Based Review.

Dos Santos BS, Bordignon C, Rosa DD

Current oncology reports 2021; (23(6)):63 doi:10.1007/s11912-021-01055-5.

Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group.

Meduri B, De Rose F, Cabula C, et al.

Medical oncology (Northwood, London, England) 2021; (38(6)):67 doi:10.1007/s12032-021-01514-w.

Preconsultation compassion intervention to reduce anxiety among patients referred to a cancer center: protocol for a randomised control trial.

Winn C, Generosa G, Mazzarelli A, et al.

BMJ open 2021; (11(5)):e048201 doi:10.1136/bmjopen-2020-048201.

Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments.

Pappalardo M, Starnoni M, Franceschini G, et al.

Journal of personalized medicine 2021; (11(5)) doi:10.3390/jpm11050402.

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

Burstein HJ, Curigliano G, Thürlimann B, et al.

Annals of oncology : official journal of the European Society for Medical Oncology 2021; (32(10)):1216-1235 doi:10.1016/j.annonc.2021.06.023.

Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the Guidelines.

Lux MP, Wasner S, Meyer J, et al.

Breast care (Basel, Switzerland) 2021; (16(3)):291-298 doi:10.1159/000509127.

Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy.

Di Meglio A, Soldato D, Presti D, Vaz-Luis I

Current opinion in oncology 2021; (33(6)):553-573 doi:10.1097/CCO.0000000000000781.

Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines.

Hall LH, King NV, Graham CD, et al.

Journal of cancer survivorship : research and practice 2022; (16(6)):1296-1338 doi:10.1007/s11764-021-01114-7.

Predictors of sentinel lymph node metastasis in Chinese women with clinical T1-T2 N0 breast cancer and a normal axillary ultrasound.

Fu F, Zhang Y, Sun J, et al.

Acta radiologica (Stockholm, Sweden : 1987) 2022; (63(11)):1463-1468 doi:10.1177/02841851211054191.

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.

Kalinsky K, Barlow WE, Gralow JR, et al.

The New England journal of medicine 2021; (385(25)):2336-2347 doi:10.1056/NEJMoa2108873.

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.

Schmid P, Cortes J, Dent R, et al.

The New England journal of medicine 2022; (386(6)):556-567 doi:10.1056/NEJMoa2112651.

Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer.

Harbeck N

Breast (Edinburgh, Scotland) 2022; (62 Suppl 1()):S12-S16 doi:10.1016/j.breast.2022.01.006.

Multidisciplinary Management of Breast Cancer and Role of the Patient Navigator.

Fenton A, Downes N, Mendiola A, et al.

Obstetrics and gynecology clinics of North America 2022; (49(1)):167-179 doi:10.1016/j.ogc.2021.11.011.

Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study.

Moskalewicz A, Di Tomaso A, Kachura JJ, et al.

Current oncology (Toronto, Ont.) 2022; (29(3)):1813-1827 doi:10.3390/curroncol29030149.

Breast Radiotherapy after Oncoplastic Surgery-A Multidisciplinary Approach.

Metz G, Snook K, Sood S, et al.

Cancers 2022; (14(7)) doi:10.3390/cancers14071685.

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update.

Andre F, Ismaila N, Allison KH, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022; (40(16)):1816-1837 doi:10.1200/JCO.22.00069.

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.

Cold S, Cold F, Jensen MB, et al.

Journal of the National Cancer Institute 2022; (114(10)):1347-1354 doi:10.1093/jnci/djac112.

Perivascular infiltration reflects subclinical lymph node metastasis in invasive lobular carcinoma.

Igawa A, Mizukami H, Kudoh K, et al.

Virchows Archiv : an international journal of pathology 2022; (481(4)):533-543 doi:10.1007/s00428-022-03391-8.

Triple-negative breast cancer and radiation therapy.

de Faria Bessa J, Marta GN

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 2022; (27(3)):545-551 doi:10.5603/RPOR.a2022.0025.

The validity and clinical utility of axillary ultrasonography-guided fine needle aspiration biopsy in detection of nodal metastasis in early-stage breast cancer patients: a retrospective single-center experience.

Taşçı F, Metin Y, Metin NO, et al.

Turkish journal of medical sciences 2022; (52(4)):1160-1168 doi:10.55730/1300-0144.5419.

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial.

Vrselja A, Latifi A, Baber RJ, et al.

Lancet (London, England) 2022; (400(10364)):1704-1711 doi:10.1016/S0140-6736(22)01977-8.

LONG-TERM SURVIVAL EFFECTS OF PREOPERATIVE BREAST MRI IN PATIENTS WITH BREAST-CONSERVING SURGERY.

Ilgun AS, Sarsenov D, Alco G, et al.

Acta clinica Croatica 2022; (61(1)):30-37 doi:10.20471/acc.2022.61.01.04.

Impact of Preoperative Extramammary Findings in Patients with Newly Diagnosed Breast Cancer.

Gleckler L, Roy N, Bernstein M, et al.

Journal of the American College of Surgeons 2023; (236(5)):1047-1053 doi:10.1097/XCS.0000000000000605.

The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations.

Finkelman BS, Zhang H, Hicks DG, Turner BM

Cancers 2023; (15(3)) doi:10.3390/cancers15030808.

Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects.

Rojas K, Spring LM, O'Riordan L, Weiss A

Annals of surgical oncology 2023; (30(10)):5951-5961 doi:10.1245/s10434-023-13907-4.

Evaluation of Axilla With Sentinel Lymph Node Biopsy (Using Methylene-Blue) and Reverse Axillary Mapping (Using Fluorescein) to Validate Optimum and Safe Axillary Dissection in Breast Cancer.

Puthangot A, Chintamani C, Tandon M

Cureus 2023; (15(9)):e45267 doi:10.7759/cureus.45267.

Cancer survivor late-effects, chronic health problems after cancer treatment: what's the evidence from population and registry data and where are the gaps?

Faithfull S, Greenfield D

Current opinion in supportive and palliative care 2024; (18(1)):55-64 doi:10.1097/SPC.0000000000000692.

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.

Gnant M, Frantal S, Pfeiler G, et al.

NEJM evidence 2022; (1(12)):EVIDoa2200162 doi:10.1056/EVIDoa2200162.

Evaluation of Palpable Breast Abnormalities.

Dodelzon K, Katzen JT

Journal of breast imaging 2019; (1(3)):253-263 doi:10.1093/jbi/wbz040.

The Effect of Exercise on Reducing Lymphedema Severity in Breast Cancer Survivors.

Lian Y, Sandhu S, Asefa Y, Gupta A

Cancers 2024; (16(7)) doi:10.3390/cancers16071367.

Monitoring for Breast Cancer Recurrence Following Goldilocks Breast Reconstruction.

Wang J, Ghanouni A, Losken A, Thompson P

Annals of plastic surgery 2024; (92(6S Suppl 4)):S432-S436 doi:10.1097/SAP.0000000000003952.

Acupuncture for hot flashes in hormone receptor-positive breast cancer: A pooled analysis of individual patient data from parallel randomized trials.

Lu W, Giobbie-Hurder A, Tanasijevic A, et al.

Cancer 2024; (130(18)):3219-3228 doi:10.1002/cncr.35374.

Correlation of tumor budding with a novel and other established prognostic parameters in patients with invasive breast carcinoma.

Borde ND, Thesiya YM, Mahajan MS, Bhale CP

Indian journal of pathology & microbiology 2025; (68(2)):310-316 doi:10.4103/ijpm.ijpm_920_23.

E-Cadherin-Mediated Cell-Cell Adhesion and Invasive Lobular Breast Cancer.

Bullock E, Brunton VG

Advances in experimental medicine and biology 2025; (1464()):259-275 doi:10.1007/978-3-031-70875-6_14.

Optimal extension time after initial endocrine therapy for postmenopausal hormone receptor-positive early-stage breast cancer: a systematic review and meta-analysis.

Ying Z, Linxun L, Kechang Z, et al.

BMC women's health 2025; (25(1)):156 doi:10.1186/s12905-025-03610-9.

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update.

Park KU, Somerfield MR, Anne N, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025; (43(14)):1720-1741 doi:10.1200/JCO-25-00099.

Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes.

Freitas AJA, Causin RL, Calfa S, et al.

Breast cancer research and treatment 2025; (212(2)):237-250 doi:10.1007/s10549-025-07718-2.

Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection in Breast Cancer: The FARM Trial.

Nguyen CL, Poels D, Teoh B, et al.

Annals of surgical oncology 2025; (32(12)):8701-8709 doi:10.1245/s10434-025-17703-0.

Impact of Endocrine Therapy on Osteoporosis Risk in Women with Breast Cancer Across Different Hormonal Stages: A Review.

Gomes B, Vale N

Current oncology (Toronto, Ont.) 2025; (32(6)) doi:10.3390/curroncol32060305.

Update in lobular breast lesions: Pathological diagnosis in the molecular era.

Bai L, Troxell ML

Human pathology 2025; (162()):105857 doi:10.1016/j.humpath.2025.105857.

AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.

Reimer T, Kuehn T, Mueller V, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(11)):110445 doi:10.1016/j.ejso.2025.110445.

Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review and economic evaluation.

Tappenden P, Cooper K, Hamilton J, et al.

Health technology assessment (Winchester, England) 2025; (29(49)):1-158 doi:10.3310/KGFD4040.

Radiotherapy of breast cancer: 2025 update.

Ghannam Y, Le Scodan R, Rivera S, et al.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2025; (29(7-8)):104767 doi:10.1016/j.canrad.2025.104767.

Not All Bone Lesions After Breast Cancer Treatment Indicate Metastasis: A Case Report and Review of the Literature.

Kaakoua M, Mohamed Amine A, Ebbadi N, et al.

Cureus 2025; (17(11)):e96191 doi:10.7759/cureus.96191.

Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimization.

Curigliano G, Marotti L, Barrios C, et al.

Breast (Edinburgh, Scotland) 2026; (85()):104682 doi:10.1016/j.breast.2025.104682.

Effects of Early Preventive Interventions on Breast Cancer-Related Lymphedema: A Meta-Analysis and Systematic Review.

Wu Y, Zhou Z, Li J, et al.

Cancer nursing 2026; doi:10.1097/NCC.0000000000001557.

Implementing a System-Wide Comprehensive Cancer Navigation Program in a Rapidly Expanding Health System.

Hohenleitner JT, Koti S, Hyman D, et al.

JCO oncology practice 2026; OP2501088 doi:10.1200/OP-25-01088.

Cardiovascular care in adult cancer survivorship post-therapy: a cross-sectional analysis of clinical practice guidelines.

Ayoson J, Schneider N, Müller N, et al.

Cardio-oncology (London, England) 2026; (12(1)).

Axillary dissection vs. non-axillary dissection in breast cancer patients with sentinel lymph node metastasis: An updated systematic review and meta-analysis of randomized clinical trials.

Castelo Branco PES, Carneiro IMC, Franco AHS, et al.

Surgical oncology 2026; (66()):102442 doi:10.1016/j.suronc.2026.102442.

Genitourinary syndrome of menopause in women with cancer - a narrative review.

Ryan HM, Brennan DJ

Maturitas 2026; (211()):109004 doi:10.1016/j.maturitas.2026.109004.

Liquid biopsy in solid tumours: expert opinion paper of the European society of pathology.

Fusco N, Matias-Guiu X, Esposito I, et al.

Virchows Archiv : an international journal of pathology 2026; doi:10.1007/s00428-026-04690-0.